| # | Drug | Count |
|---|---|---|
| 0 | FINGOLIMOD HCL | 865 |
| 1 | RANIBIZUMAB | 583 |
| 2 | BEVACIZUMAB | 340 |
| 3 | AFLIBERCEPT | 267 |
| 4 | ADALIMUMAB | 260 |
| 5 | ASPIRIN | 218 |
| 6 | ASPIRIN 325 MG | 214 |
| 7 | ASPIRIN 81 MG | 214 |
| 8 | PACLITAXEL | 191 |
| 9 | METHOTREXATE SODIUM | 177 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BALANCED SALT SOLUTION ENRICHED WITH BICARBONATE, DEXTROSE, AND GLUTATHIONE | 26 | 0.0708 |
| 1 | OMIDENEPAG ISOPROPYL | 4 | 0.0606 |
| 2 | TROPICAMIDE | 49 | 0.0300 |
| 3 | ACYCLOVIR AND HYDROCORTISONE | 1 | 0.0250 |
| 4 | VERTEPORFIN FOR INJECTION | 37 | 0.0250 |
| 5 | RANIBIZUMAB | 583 | 0.0220 |
| 6 | NEPAFENAC | 70 | 0.0219 |
| 7 | ESTRADIOL VALERATE | 15 | 0.0193 |
| 8 | CEFUROXIME SODIUM | 21 | 0.0171 |
| 9 | TRAVOPROST INTRACAMERAL | 2 | 0.0169 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 955 |
| 1 | Corticosteroid [EPC] | 503 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 396 |
| 3 | Insulin Analog [EPC] | 283 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 247 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 221 |
| 6 | Microtubule Inhibitor [EPC] | 206 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 164 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 163 |
| 9 | Prostaglandin Analog [EPC] | 159 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Diagnostic Dye [EPC] | 7 | 0.0108 |
| 1 | Photoenhancer [EPC] | 41 | 0.0105 |
| 2 | Antiseptic [EPC] | 43 | 0.0098 |
| 3 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 127 | 0.0092 |
| 4 | Antileishmanial [EPC] | 3 | 0.0077 |
| 5 | alpha-1 Adrenergic Agonist [EPC] | 28 | 0.0063 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 955 | 0.0052 |
| 7 | Antihypoglycemic Agent [EPC] | 19 | 0.0044 |
| 8 | Provitamin D2 Compound [EPC] | 124 | 0.0042 |
| 9 | Anticholinergic [EPC] | 51 | 0.0031 |